SARS-CoV-2 variants and vaccines

Philip R. Krause; Thomas R. Fleming; Ira M. Longini; Richard Peto; Sylvie Briand; David L. Heymann; Valerie Beral; Matthew D. Snape; Helen Rees; Alba Maria Ropero; Ran Balicer; Jakob P. Cramer; César Muñoz‑Fontela; Marion Gruber; Rogerio Gaspar; Jerome A. Singh; Kanta Subbarao; Maria D. van Kerkhove; Soumya Swaminathan; Michael J. Ryan; Ana Maria Henao-Restrepo

doi:10.1056/NEJMsr2105280

SARS-CoV-2 variants and vaccines

Philip R. Krause, Thomas R. Fleming, Ira M. Longini, Richard Peto, Sylvie Briand, David L. Heymann, Valerie Beral, Matthew D. Snape, Helen Rees, Alba Maria Ropero, Ran Balicer, Jakob P. Cramer, César Muñoz‑Fontela, Marion Gruber, Rogerio Gaspar, Jerome A. Singh, Kanta Subbarao, Maria D. van Kerkhove, Soumya Swaminathan, Michael J. RyanAna Maria Henao-Restrepo

Research output: Contribution to journal › Article › peer-review

291 Scopus citations

Abstract

Viral variants of concern may emerge with dangerous resistance to the immunity generated by the current vaccines to prevent coronavirus disease 2019 (Covid-19). Moreover, if some variants of concern have increased transmissibility or virulence, the importance of efficient public health measures and vaccination programs will increase. The global response must be both timely and science based.

Original language	English
Pages (from-to)	179-186
Number of pages	8
Journal	New England Journal of Medicine
Volume	385
Issue number	2
DOIs	https://doi.org/10.1056/NEJMsr2105280
State	Published - 8 Jul 2021
Externally published	Yes

ASJC Scopus subject areas

General Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1056/NEJMsr2105280

Cite this

Krause, P. R., Fleming, T. R., Longini, I. M., Peto, R., Briand, S., Heymann, D. L., Beral, V., Snape, M. D., Rees, H., Ropero, A. M., Balicer, R., Cramer, J. P., Muñoz‑Fontela, C., Gruber, M., Gaspar, R., Singh, J. A., Subbarao, K., van Kerkhove, M. D., Swaminathan, S., ... Henao-Restrepo, A. M. (2021). SARS-CoV-2 variants and vaccines. New England Journal of Medicine, 385(2), 179-186. https://doi.org/10.1056/NEJMsr2105280

@article{ad14ecf52ee64edeabb7a6e7473a7f56,

title = "SARS-CoV-2 variants and vaccines",

abstract = "Viral variants of concern may emerge with dangerous resistance to the immunity generated by the current vaccines to prevent coronavirus disease 2019 (Covid-19). Moreover, if some variants of concern have increased transmissibility or virulence, the importance of efficient public health measures and vaccination programs will increase. The global response must be both timely and science based.",

author = "Krause, {Philip R.} and Fleming, {Thomas R.} and Longini, {Ira M.} and Richard Peto and Sylvie Briand and Heymann, {David L.} and Valerie Beral and Snape, {Matthew D.} and Helen Rees and Ropero, {Alba Maria} and Ran Balicer and Cramer, {Jakob P.} and C{\'e}sar Mu{\~n}oz‑Fontela and Marion Gruber and Rogerio Gaspar and Singh, {Jerome A.} and Kanta Subbarao and {van Kerkhove}, {Maria D.} and Soumya Swaminathan and Ryan, {Michael J.} and Henao-Restrepo, {Ana Maria}",

note = "Publisher Copyright: Copyright {\textcopyright} 2021 Massachusetts Medical Society.",

year = "2021",

month = jul,

day = "8",

doi = "10.1056/NEJMsr2105280",

language = "English",

volume = "385",

pages = "179--186",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "2",

}

Krause, PR, Fleming, TR, Longini, IM, Peto, R, Briand, S, Heymann, DL, Beral, V, Snape, MD, Rees, H, Ropero, AM, Balicer, R, Cramer, JP, Muñoz‑Fontela, C, Gruber, M, Gaspar, R, Singh, JA, Subbarao, K, van Kerkhove, MD, Swaminathan, S, Ryan, MJ & Henao-Restrepo, AM 2021, 'SARS-CoV-2 variants and vaccines', New England Journal of Medicine, vol. 385, no. 2, pp. 179-186. https://doi.org/10.1056/NEJMsr2105280

TY - JOUR

T1 - SARS-CoV-2 variants and vaccines

AU - Krause, Philip R.

AU - Fleming, Thomas R.

AU - Longini, Ira M.

AU - Peto, Richard

AU - Briand, Sylvie

AU - Heymann, David L.

AU - Beral, Valerie

AU - Snape, Matthew D.

AU - Rees, Helen

AU - Ropero, Alba Maria

AU - Balicer, Ran

AU - Cramer, Jakob P.

AU - Muñoz‑Fontela, César

AU - Gruber, Marion

AU - Gaspar, Rogerio

AU - Singh, Jerome A.

AU - Subbarao, Kanta

AU - van Kerkhove, Maria D.

AU - Swaminathan, Soumya

AU - Ryan, Michael J.

AU - Henao-Restrepo, Ana Maria

PY - 2021/7/8

Y1 - 2021/7/8

N2 - Viral variants of concern may emerge with dangerous resistance to the immunity generated by the current vaccines to prevent coronavirus disease 2019 (Covid-19). Moreover, if some variants of concern have increased transmissibility or virulence, the importance of efficient public health measures and vaccination programs will increase. The global response must be both timely and science based.

AB - Viral variants of concern may emerge with dangerous resistance to the immunity generated by the current vaccines to prevent coronavirus disease 2019 (Covid-19). Moreover, if some variants of concern have increased transmissibility or virulence, the importance of efficient public health measures and vaccination programs will increase. The global response must be both timely and science based.

UR - http://www.scopus.com/inward/record.url?scp=85109559028&partnerID=8YFLogxK

U2 - 10.1056/NEJMsr2105280

DO - 10.1056/NEJMsr2105280

M3 - Article

C2 - 34161052

AN - SCOPUS:85109559028

SN - 0028-4793

VL - 385

SP - 179

EP - 186

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 2

ER -

SARS-CoV-2 variants and vaccines

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this